Skip to main content

Closed

NRSN: NeuroSense Therapeutics Ltd. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

2thpctl

Volume

0.51×avg

Market Cap

16.44MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

NeuroSense Therapeutics Ltd.

NRSNNASDAQ Capital Market·USD·Closed

NeuroSense Therapeutics Ltd.

NRSNNASDAQ·USD·Closed

$0.47

−2.27%

$0.47

−$0.01 (2.27%)

52W Range

2thpctl

Volume

0.51×avg

Mkt Cap

16.44MUSD

P/E

-1.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings